Diabetes and Endocrinology Support
A Contract Award Notice
by UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST
- Source
- Find a Tender
- Type
- Contract (Services)
- Duration
- not specified
- Value
- 45K
- Sector
- HEALTH
- Published
- 06 Feb 2025
- Delivery
- not specified
- Deadline
- n/a
Concepts
Location
Birmingham:
1 buyer
- University Hospitals Birmingham NHS Trust Birmingham
1 supplier
- South Doc Services Birmingham
Description
Support to UHB FT Diabetes & Endocrinology integrated with the Trust's current services to support national and regional performance targets.
Total Quantity or Scope
Support to UHB NHS FT Diabetes & Endocrinology service integrated with the Trust's current services to support national and regional performance targets.UHB NHS FT are intending to award to an existing Provider following Direct Award C.The approximate value is £45,000. Award is to cover service for a period of two months.
Award Detail
| 1 | South Doc Services (Birmingham)
|
Award Criteria
| The existing provider is satisfying the original contract and will likely satisfy the proposed contract to a sufficient standard | 100 |
| price | 0 |
CPV Codes
- 85112200 - Outpatient care services
Legal Justification
This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to the relevant authority by 19/02/2025. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR
Other Information
** PREVIEW NOTICE, please check Find a Tender for full details. ** This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to decision makers by 19/02/2025 via email address razib.riaz@uhb.nhs.uk. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.The principle decision maker is Thomas Lowbridge (General Manager - Renal, Endocrinology, Diabetes & Metabolism)Conflicts of interest identified among [group/committee/officer]: None.The provider has a proven track record of delivery in line with NHS expectations of the contract and has been an effective partner in the elective recovery of the Birmingham and Solihull system. The existing provider is satisfying the original contract and will likely satisfy the proposed contract to a sufficient standard.The proposed contract is a 8 week renewal of an existing contract to continue to support with elective recovery targets and the delivery of patient care. The intention of the Trust is to bring this activity back in house from May 2025.Due to the short nature of the proposed contract it was decided that it would not be proportionate or represent value for money to undertake a competitive exercise due to the requirement for any new provider to mobilise for in a short space of time for a relatively short contractual period.
Reference
- ocds-h6vhtk-04dc0f
- FTS 003898-2025